Clinical Trial Update: A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women [Phase 3]

View source ↗

Summary

This completed Phase 3, single-arm, open-label pharmacokinetic study evaluated multiple antiretroviral combinations (darunavir with ritonavir or cobicistat, etr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Edurant (rilpivirine)
• Intelence (Etravirine)
• Norvir (ritonavir)
• PREZISTA (darunavir)
• Tybost (Cobicistat)

Snippet

Sponsor: Janssen Scientific Affairs, LLC | Conditions: HIV, HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2017-09-15